| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.01. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - FDA APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION FOR ADASUVE | - | HKEx | ||
| 22.12.25 | LEE'S PHARM (00950): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO DISCLOSEABLE TRANSACTION - ACQUISITION OF ASSETS | 5 | HKEx | ||
| 18.12.25 | LEE'S PHARM (00950): PASSING AWAY OF MICHELE DALLA LIBERA | 1 | HKEx | ||
| 11.12.25 | Lee's Pharmaceutical Holdings Limited: Lee's Pharmaceutical Holdings Limited Acquires Staccato One Breath Technology Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights | 505 | PR Newswire | Acquisition of Staccato One Breath Technology, a proprietary platform technology with broad therapeutic potentialSynergistic and complementary to Lee's Pharm's existing products pipeline... ► Artikel lesen | |
| LEES PHARMACEUTICAL Aktie jetzt für 0€ handeln | |||||
| 11.12.25 | Lee's Pharmaceutical Holdings Limited Acquires Staccato One Breath Technology Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights | 311 | PR Newswire | Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic potential
Synergistic and complementary to Lee's Pharm's existing products... ► Artikel lesen | |
| 08.12.25 | LEE'S PHARM (00950): DISCLOSEABLE TRANSACTION - ACQUISITION OF ASSETS | 1 | HKEx | ||
| 15.10.25 | LEE'S PHARM (00950): GRANT OF SHARE OPTIONS | 2 | HKEx | ||
| 19.09.25 | LEE'S PHARM (00950): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF INTERIM REPORT | - | HKEx | ||
| 19.09.25 | LEE'S PHARM (00950): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF INTERIM REPORT | 1 | HKEx | ||
| 19.09.25 | LEE'S PHARM (00950): INTERIM REPORT 2025 | 1 | HKEx | ||
| 12.09.25 | Dividendenbekanntmachungen (12.09.2025) | 12.662 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABSA GROUP LIMITED ADR US00400T1025 0,887 USD 0,7558 EUR ACADIAN ASSET MANAGEMENT INC US10948W1036 0,01 USD 0,0085 EUR ALBEMARLE... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 128,36 | +1,81 % | Gilead Sciences schlägt zu - 68 Prozent Aufschlag | Die US-amerikanische Biotech-Gesellschaft Gilead Sciences will sich im Bereich der Onkologie verstärken. Mit der geplanten Übernahme von Arcellx erwirbt das Unternehmen die volle Kontrolle über eine... ► Artikel lesen | |
| ZOETIS | 109,26 | -1,55 % | Zoetis Inc. to Acquire Animal Genomics Business from Neogen, Accelerating Precision Animal Health Innovation | Acquisition strengthens Zoetis' leadership in Precision Animal Health by integrating Neogen's global genomics capabilities, expanding predictive insights and individualized care worldwide
PARSIPPANY... ► Artikel lesen | |
| SINOPHARM | 2,329 | +2,69 % | HSI Closes at 26,765, Up 175 pts; HSTI Closes at 5,260, Down 10 pts; HAIDILAO Up over 6%; HSBC HOLDINGS, TINGYI, SINOPHARM, TIME INTERCON, WANGUO GOLD GP Hit New Highs; Market Turnover Rises | ||
| CSPC PHARMA | 1,044 | -1,93 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION, RAPID SUSPENSION (ALBUMIN-BOUND) (SYHX2011G1) ... | ||
| WUXI BIOLOGICS | 4,201 | -3,26 % | CLSA Favors CDMOs for Earnings Visibility, Top Picks WUXI APPTEC/WUXI BIO/PHARMARON | ||
| SHANGHAI FOSUN PHARMACEUTICAL | 2,120 | -2,21 % | FOSUN PHARMA (02196): POLL RESULTS OF THE RESOLUTIONS PROPOSED AT THE 2026 FIRST EXTRAORDINARY GENERAL MEETING, THE 2026 FIRST A SHAREHOLDERS' CLASS ... | ||
| GEDEON RICHTER | 30,340 | -3,31 % | Gedeon Richter Plc.: Voting rights, registered capital | ||
| DR REDDYS | 12,000 | -4,00 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| MEDIPHARM LABS | 0,042 | -5,78 % | Schreiner MediPharm, OECHSLERhealth Introduce Cap-Lock for Vials | ||
| ASPEN PHARMACARE | 7,250 | +2,84 % | Dividendenbekanntmachungen (01.10.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACRES COMMERCIAL REALTY CORP PFD D US00489Q3002 0,4921 USD 0,4193 EUR AECOM US00766T1007 0,26 USD 0,2215 EUR AFRICAN RAINBOW MINERALS... ► Artikel lesen | |
| SHANGHAI PHARMACEUTICALS | 1,320 | +4,76 % | Dividendenbekanntmachungen (29.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADWAYS INC JP3121970002 6,35 JPY 0,0344 EUR AGC INC JP3112000009 105 JPY 0,5701 EUR AMERICAN TOWER CORPORATION US03027X1000 1... ► Artikel lesen | |
| LUYE PHARMA | 0,270 | -2,17 % | LUYE PHARMA (02186): DISCLOSEABLE AND CONNECTED TRANSACTION CAPITAL INJECTION IN NANJING LUYE | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,157 | -4,85 % | Dividendenbekanntmachungen (26.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADF GROUP INC CA00089N1033 0,02 CAD 0,0123 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0,21 USD 0,18 EUR ALICO INC US0162301040 0... ► Artikel lesen | |
| CHINA RESOURCES PHARMACEUTICAL | 0,480 | -0,41 % | Dividendenbekanntmachungen (11.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADEMY SPORTS AND OUTDOORS INC US00402L1070 0,13 USD 0,1111 EUR ACTIA GROUP SA FR0000076655 - 0,12 EUR ADT INC US00090Q1031 0... ► Artikel lesen | |
| HANSOH PHARMACEUTICAL | 3,720 | -1,59 % | HANSOH PHARMA (03692): VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION OF DALMELITINIB MESYLATE TABLETS WAS ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION |